IBC Legal is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


24th & 25th October 2018
London, UK

Life Sciences IP Minds Conference

Created by the industry, for the industry.

Hear from top IP legal minds and discuss how international regulation, technology & data and changing strategies are going to shape the life sciences industry.


Life Sciences IP Minds 2018 is now open for registration. Book now and benefit from a 50% discount if you are an in-house counsel!

Interested in becoming a partner for this event? Find out more information here. 

Examine the key challenges facing the life sciences industry and prepare your IP for the future

Update on the UPC
  • Discuss the key benefits of opting in or out of the unified patent 
  • Learn about the ramifications the UPC will have on the SPC model
  • Explore the recent CJEU referrals and what they mean for the SPC
Thrive in an uncertain political climate
  • Renowned IP litigator Ken Adamo of Kirkland & Ellis LLP to provide a practical understanding of the latest case law and regulation
  • Explore how recent and pending Supreme Court judgements will affect IP filing and delivery
  • A broad discussion on preparing your IP for entry in post-Brexit Britain
Stay ahead of the competition with your biological patent strategy
  • Ensure your IP is defensible and robust by understanding the shifting landscape 
  • Formulate a winning IP litigation strategy with top barristers and legal minds
  • Get the latest news on biotech diagnostic testing
Key market access strategies for commercially focused IP
  • Overcome the barriers to market access for biosimilar and biobetter products
  • Find out the latest regarding Pregabalin and its disruptive effect on the second medical use patent
  • Discover how the EU Commission and FDA proposals to change orphan drug classification will change your IP strategy
Staying compliant with regulations and authorities
  • Unravel the requirements needed to ensure your IP is a success
  • Learn to balance sufficiency and speed
  • Explore the pricing pitfalls to consider as an IP practitioner 
  • Uncover the complex relationship between transparency/patient rights and your rights as a patent holder
Network with top IP minds

Representatives from across Europe will gather to share their insight and knowledge with the Life Sciences IP community. You will have a chance to discuss the latest issues affecting you and your team through Q+A sessions, lunches and networking breaks

Sponsorship Opportunities